YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Hair Loss Associated With Paroxetine Use: a Case Report

dc.authorid Kamis, Gulsum Zuhal/0000-0003-1091-5602
dc.authorid Kurhan, Faruk/0000-0003-3718-0458
dc.authorscopusid 57217966676
dc.authorscopusid 56095149100
dc.authorwosid Kamis, Gulsum Zuhal/Hsh-3135-2023
dc.authorwosid Kurhan, Faruk/Ivu-6511-2023
dc.contributor.author Kurhan, Faruk
dc.contributor.author Kamis, Gulsum Zuhal
dc.date.accessioned 2025-05-10T17:09:38Z
dc.date.available 2025-05-10T17:09:38Z
dc.date.issued 2021
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Kurhan, Faruk] Van Yuzuncu Yil Univ, Med Fac, Dept Psychiat, Hosp Dursun Odabas Med Ctr, Van, Turkey; [Kamis, Gulsum Zuhal] Akhisar Mustafa Kirazoglu State Hosp, Dept Psychiat, Manisa, Turkey en_US
dc.description Kamis, Gulsum Zuhal/0000-0003-1091-5602; Kurhan, Faruk/0000-0003-3718-0458 en_US
dc.description.abstract Diverse dermatological side effects in relation to using psychotropic agents, include the serious outcomes as hypersensitivity and Stevens-Johnson syndrome as well as milder forms as ecchymosis and hair loss. Whereas hair loss is frequently associated with mood stabilizers, rarely it is also attributed to antidepressants. Selective serotonin reuptake inhibitors (SSRIs) which arc the first choice treatment for depression, anxiety disorders and obsessive-compulsive spectrum disorders, are the most commonly used antidepressant drugs. Psychiatric comorbidities have been known in many dermatological diseases and their treatment have positive effects on the course and outcome as well as on the adaptation process to the disease. Due to their favorable side effect profile, for comorbid cases SSRIs are frequently used. Here we present a case of hair loss during paroxetine in a 24-yearold male with social anxiety disorder. In this case the hair loss improved after discontinuing and recurred after resuming paroxetine. After replacing paroxetine with sertraline, another SSRI, alopecia did not recur. en_US
dc.description.woscitationindex Social Science Citation Index
dc.identifier.doi 10.5080/u24955
dc.identifier.endpage 64 en_US
dc.identifier.issn 1300-2163
dc.identifier.issue 1 en_US
dc.identifier.pmid 34181746
dc.identifier.scopus 2-s2.0-85109628312
dc.identifier.scopusquality Q3
dc.identifier.startpage 61 en_US
dc.identifier.trdizinid 533105
dc.identifier.uri https://doi.org/10.5080/u24955
dc.identifier.uri https://hdl.handle.net/20.500.14720/7196
dc.identifier.volume 32 en_US
dc.identifier.wos WOS:000697191100009
dc.identifier.wosquality Q4
dc.language.iso en en_US
dc.publisher Turkiye Sinir ve Ruh Sagligi dernegi en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Alopecia en_US
dc.subject Antidepressants en_US
dc.subject Paroxetine en_US
dc.subject Hair Loss en_US
dc.title Hair Loss Associated With Paroxetine Use: a Case Report en_US
dc.type Article en_US

Files